HER2-Positive Breast Cancer | Erika Hamilton, MD

Beyond the Guidelines: Clinical Investigator Perspectives on the Management of HER2-Positive Breast Cancer — Faculty Presentation 2: Incidence and Management of Adverse Events Associated with HER2-Targeted Therapy — Dr Hamilton. CME information and select publications